期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物治疗肺动脉高压的作用及机制 被引量：4

原文传递
导出
摘要 越来越多的证据证实他汀类药物有降低胆固醇作用之外的多效性作用,也被认为是有潜力的治疗肺动脉高压（PAH）的药物.本文就他汀类药物治疗PAH的作用及机制方面的动物实验及临床研究进展综述如下.
作者 卢献灵 何建国
机构地区 北京协和医学院中国医学科学院阜外心血管病医院
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2010年第10期954-957,共4页 Chinese Journal of Cardiology
关键词 他汀类药物 肺动脉高压 药物治疗 低胆固醇 进展综述 临床研究 动物实验 多效性
分类号 R972.6 [医药卫生—药品]
  • 相关文献

参考文献32

  • 1McLaughlin W,Archer SL,Badesch DB,et al.ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society,Inc.; and the Pulmonary Hypertension Association.J Am Coll Cardiol,2009,53:1573-1619.
  • 2Eddahibi S,Morrell N,d' Ortho MP,et al.Pathobiology of pulmonary arterial hypertension.Eur Respir J,2002,20:1559 -1572.
  • 3Nishimura T,Vaszar LT,Faul JL,et al Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.Circulation,2003,108:1640-1645.
  • 4Satoh K,Fukumoto Y,Nakano M,et al.Statin ameliorates hypoxia-induced pulmonary hypertension associated with down regulated stromal cell-derived factor-1.Cardiovasc Res,2009,81:226-234.
  • 5Hsu HH,Ko WJ,Hsu JY,et al.Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1dependent pathway in rats.Respir Res,2009,10:32.
  • 6张伟华,陆慰萱,张运剑,季颖群,刘春萍,李国.辛伐他汀对野百合碱致肺动脉高压大鼠肺血管病变的影响[J].中华医学杂志,2009,89(12):855-859. 被引量：8
  • 7陈建英,黄石安,杨宇,陈灿,陈晓于,陈亮波,刘珍君,谢晓明.辛伐他汀对野百合碱诱导肺动脉高压大鼠肺组织中NF-κB表达及血清C反应蛋白和TNF-α水平的影响[J].广东医学院学报,2009,27(4):363-366. 被引量：3
  • 8Nishimura T,Faul JL,Berry GJ,et al.Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.Am J Respir Crit Care Med,2002,166:1403-1408.
  • 9Girgis RE,Mozammel S,Champion HC,et al.Regression of chronic hypoxic pulmonary hypertension by simvastatin.Am J Physiol Lung Cell Mol Physiol,2007,292:L1105-1110.
  • 10Murata T,Kinoshita K,Hori M,et al.Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.Arterioscler Thromb Vasc Biol,2005,25:2335-2342.

二级参考文献78

  • 1王荣丽,王文军,杨小琼,王曾礼.肿瘤坏死因子介导缺氧性肺动脉高压的实验研究[J].中国现代医药杂志,2004,6(5):24-26. 被引量：5
  • 2张冬颖,覃数,唐显军,杨辉.辛伐他汀对心肌梗死后大鼠心肌间质重构的影响[J].中国药理学通报,2007,23(4):516-520. 被引量：9
  • 3邢西迁,甘烨,吴尚洁.他汀类药物治疗肺动脉高压作用机制的研究进展[J].国际呼吸杂志,2007,27(10):794-797. 被引量：4
  • 4夏秀琼,程德云,苏巧俐,陈小菊,杨莉.斯伐他汀抑制血管紧张素-Ⅱ受体1的表达,预防大鼠低氧性肺动脉高压[J].中国呼吸与危重监护杂志,2007,6(3):213-216. 被引量：8
  • 5孙波 刘文利.右心导管法测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6(2):465-465.
  • 6Bellisarii FL, Gallina S, De Caterina R. Tumor nercosis factor- alpha and cardiovascular diseases. Ital Heart J, 2001, 2: 408- 417.
  • 7Nishimura T, Vsazar LT, Faul JL, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation, 2003, 108 : 1640- 1645.
  • 8Nishimura T, Faul JL, Berry GJ, et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med, 2002, 166:1403-1408.
  • 9] Murata T, Sato K, Hori M, et al. Decreased endothelial nitricoxide synthase(eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem, 2002, 277: 44085-44092.
  • 10Murata T, Kinoshita K, Hori M, et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vase Biol, 2005, 25 : 2335- 2342.

共引文献25

同被引文献37

  • 1邱烈.CpG岛甲基化异常的致癌作用[J].检验医学与临床,2007,4(8):746-748. 被引量：4
  • 2王红阳,张庆,郭纪全.呼吸内科疾病诊断标准[M].北京:科学技术文献出版社,2006:299-301.
  • 3Chhabra SK.Pulmonary hypertension associated with chronic obstructive pulmonary disease[J].Indian J Chest Dis Allied Sci,2010,52(1):29-40.
  • 4Young RP,Hopkins RJ.Possible role of statins in COPD-related pulmonary hypertension[J].Chest,2010,137(5):1250-1251.
  • 5Nishimura T,Vaszat LT,Faul JI.Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells[J].Circulation,2003,108(13):1640-1645.
  • 6Ito T,Ozawa K,Shimada K.Current drug targets and future therapy of pulmonary arterial hypertension[J].Curr Med Chem,2007,14(6):719-733.
  • 7Rhodes CJ,Davidson A,Gibbs JS,et al.Therapeutic targets in pulmonary arterial hypertension[J].Pharmacol Ther,2009,121(1):69-88.
  • 8Kwon YS,Chi SY,Shin HJ,et al.Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension[J].J Korean Med Sci,2010,25(10):1487-1491.
  • 9Chin KM, Rubin LJ. Pulmonar)' arterial hypertension. J Am Coil Cardiol, 2008, 51: 1527-1538.
  • 10Gali N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009, 30: 394-403.

引证文献4

二级引证文献23

中华心血管病杂志
2010年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部